219 related articles for article (PubMed ID: 10757355)
1. Adenovirus vector-mediated gene transfer to regional lymph nodes.
Labow D; Lee S; Ginsberg RJ; Crystal RG; Korst RJ
Hum Gene Ther; 2000 Mar; 11(5):759-69. PubMed ID: 10757355
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus gene transfer vectors inhibit growth of lymphatic tumor metastases independent of a therapeutic transgene.
Korst RJ; Ailawadi M; Lee JM; Lee S; Yamada R; Mahtabifard A; Crystal RG
Hum Gene Ther; 2001 Sep; 12(13):1639-49. PubMed ID: 11535167
[TBL] [Abstract][Full Text] [Related]
3. Periocular triamcinolone enhances intraocular gene expression after delivery by adenovirus.
Park CY; Chuck RS; Cano M; Yew M; Nguyen V; Parker J; Mori K; Gehlbach PL
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):399-406. PubMed ID: 18172118
[TBL] [Abstract][Full Text] [Related]
4. Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression.
Schowalter DB; Meuse L; Wilson CB; Linsley PS; Kay MA
Gene Ther; 1997 Aug; 4(8):853-60. PubMed ID: 9338015
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic injection of adenovirus reduces inflammation and increases gene transfer and therapeutic effect in mice.
Crettaz J; Berraondo P; Mauleón I; Ochoa-Callejero L; Shankar V; Barajas M; van Rooijen N; Kochanek S; Qian C; Prieto J; Hernández-Alcoceba R; González-Aseguinolaza G
Hepatology; 2006 Sep; 44(3):623-32. PubMed ID: 16941711
[TBL] [Abstract][Full Text] [Related]
6. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
Ji L; Bouvet M; Price RE; Roth JA; Fang B
Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
[TBL] [Abstract][Full Text] [Related]
7. Further reduction in adenovirus vector-mediated liver transduction without largely affecting transgene expression in target organ by exploiting microrna-mediated regulation and the Cre-loxP recombination system.
Bennett D; Sakurai F; Shimizu K; Matsui H; Tomita K; Suzuki T; Katayama K; Kawabata K; Mizuguchi H
Mol Pharm; 2012 Dec; 9(12):3452-63. PubMed ID: 23127182
[TBL] [Abstract][Full Text] [Related]
8. Lung-specific expression of adenovirus E3-14.7K in transgenic mice attenuates adenoviral vector-mediated lung inflammation and enhances transgene expression.
Harrod KS; Hermiston TW; Trapnell BC; Wold WS; Whitsett JA
Hum Gene Ther; 1998 Sep; 9(13):1885-98. PubMed ID: 9741427
[TBL] [Abstract][Full Text] [Related]
9. Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individuals.
Harvey BG; Hackett NR; Ely S; Crystal RG
Mol Ther; 2001 Feb; 3(2):206-15. PubMed ID: 11237677
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus replication-competent vectors (KD1, KD3) complement the cytotoxicity and transgene expression from replication-defective vectors (Ad-GFP, Ad-Luc).
Habib NA; Mitry R; Seth P; Kuppuswamy M; Doronin K; Toth K; Krajcsi P; Tollefson AE; Wold WS
Cancer Gene Ther; 2002 Aug; 9(8):651-4. PubMed ID: 12136425
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral delivery of adenovirus-mediated interleukin-12 gene in mice with metastatic cancer in the liver.
Sung MW; Chen SH; Thung SN; Zhang DY; Huang TG; Mandeli JP; Woo SL
Hum Gene Ther; 2002 Apr; 13(6):731-43. PubMed ID: 11936972
[TBL] [Abstract][Full Text] [Related]
12. Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver.
Alzuguren P; Hervas-Stubbs S; Gonzalez-Aseguinolaza G; Poutou J; Fortes P; Mancheno U; Bunuales M; Olagüe C; Razquin N; Van Rooijen N; Enguita M; Hernandez-Alcoceba R
Liver Int; 2015 Apr; 35(4):1274-89. PubMed ID: 24754307
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging.
Lamfers ML; Fulci G; Gianni D; Tang Y; Kurozumi K; Kaur B; Moeniralm S; Saeki Y; Carette JE; Weissleder R; Vandertop WP; van Beusechem VW; Dirven CM; Chiocca EA
Mol Ther; 2006 Dec; 14(6):779-88. PubMed ID: 16996314
[TBL] [Abstract][Full Text] [Related]
14. Viral transgene expression delivered by repeat intraocular adenoviral vector injection: in vivo live imaging study.
Gehlbach PL; Chuck RS; Park CG; Park CY
Mol Imaging; 2012; 11(5):361-71. PubMed ID: 22954180
[TBL] [Abstract][Full Text] [Related]
15. Anti-T cell receptor antibody prolongs transgene expression and reduces lung inflammation after adenovirus-mediated gene transfer.
Zsengellér ZK; Boivin GP; Sawchuk SS; Trapnell BC; Whitsett JA; Hirsch R
Hum Gene Ther; 1997 May; 8(8):935-41. PubMed ID: 9195216
[TBL] [Abstract][Full Text] [Related]
16. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.
Kaner RJ; Worgall S; Leopold PL; Stolze E; Milano E; Hidaka C; Ramalingam R; Hackett NR; Singh R; Bergelson J; Finberg R; Falck-Pedersen E; Crystal RG
Am J Respir Cell Mol Biol; 1999 Mar; 20(3):361-70. PubMed ID: 10030833
[TBL] [Abstract][Full Text] [Related]
17. Gene transfer to the pleural mesothelium as a strategy to deliver proteins to the lung parenchyma.
Mae M; Crystal RG
Hum Gene Ther; 2002 Aug; 13(12):1471-82. PubMed ID: 12215268
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice.
Hwang KS; Cho WK; Yoo J; Yun HJ; Kim S; Im DS
BMC Cancer; 2005 May; 5():51. PubMed ID: 15910693
[TBL] [Abstract][Full Text] [Related]
19. Gene delivery to in situ veins: differential effects of adenovirus and adeno-associated viral vectors.
Eslami MH; Gangadharan SP; Sui X; Rhynhart KK; Snyder RO; Conte MS
J Vasc Surg; 2000 Jun; 31(6):1149-59. PubMed ID: 10842152
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys.
Haegel-Kronenberger H; Haanstra K; Ziller-Remy C; Ortiz Buijsse AP; Vermeiren J; Stoeckel F; Van Gool SW; Ceuppens JL; Mehtali M; De Boer M; Jonker M; Boon L
Gene Ther; 2004 Feb; 11(3):241-52. PubMed ID: 14737083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
